Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 384 of 6351
-
Can an AI eye guide surgeons to safer, faster cancer removal?
Disease control Not yet recruitingIn this prospective paired diagnostic study and single-center, randomized controlled trial, patients with early esophageal squamous neoplasia or high-grade intraepithelial neoplasia meeting the inclusion and exclusion criteria will be enrolled in a paired diagnostic cohort (60 pa…
Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a wearable light device lift the fog of postpartum depression?
Symptom relief Recruiting nowThe proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a muscle relaxant speed up recovery after pelvic surgery?
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether adding tizanidine to the standard postoperative pain regimen improves recovery after pelvic reconstructive surgery in adult women. The main questions it aims to answer are: Does postoperative tizanidine improve patient-repor…
Phase 2 • Sponsor: Hartford Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Calming senses before surgery: a new way to soothe anxious kids?
Symptom relief Not yet recruitingEncounters with healthcare services during childhood, particularly surgical evaluation processes, are a significant source of stress for both children and their parents. The initial evaluation, physical examination, and the prospect of a possible procedure conducted in pediatric …
Sponsor: Bilecik Seyh Edebali Universitesi • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could a smartphone app be the key to better diabetes control?
Disease control Recruiting nowThe purpose of the study is to see if using a diabetes app along with nutrition counseling from a registered dietitian nutritionist can help improve blood sugars and cholesterol levels, quality of life, physical activity, and food and beverage choices.
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for rare brain disease: platform trial targets PSP
Disease control Recruiting nowThe Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.
Phase 2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a Two-Dose drug delay type 1 diabetes as well as a 14-Day treatment?
Disease control Recruiting nowThis is a 2-arm, multi-center, open label study to learn if ATG works the same or better than teplizumab in delaying or preventing Stage 3 Type 1 diabetes. Participants will be administered either 2 infusions of ATG or 14 infusions of teplizumab and will then be followed for at l…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 10, 2026 04:00 UTC
-
Could a simple eye drop shield your cornea during cataract surgery?
Prevention Recruiting nowThis study is designed to assess whether an investigational eye drop called CA201A can help protect the cornea (the outer covering of the eye) and reduce damage to corneal endothelial cells following cataract surgery, without causing significant side effects. Cataract surgery is …
Phase 2 • Sponsor: Caravel Oculus Pty Ltd • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Experimental drug SHR-A1904 takes on Hard-to-Treat colorectal cancer
Disease control Not yet recruitingTo evaluate the safety and efficacy of SHR-A1904 in the advanced colorectal cancer after failure of standard therapy
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Color-Coded triage: a quick way to spot sick kids?
Knowledge-focused Recruiting nowThis multicenter prospective observational cohort study evaluates how well the initial triage category assigned by the Turkish Ministry of Health three-level color-coded triage system (Red-Yellow-Green) predicts serious clinical outcomes in children aged 0-18 years who present wi…
Sponsor: TC Erciyes University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can AI turn routine scans into a bone health check?
Diagnosis OngoingThe goal of this clinical trial is to test if an artificial intelligence (AI) tool called DeepBMD can accurately identify people at high risk for osteoporosis using routine chest or abdomen CT scans. The main questions it aims to answer are: 1. Can the DeepBMD tool correctly ide…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
Can tailored nutrition boost recovery in the ICU?
Disease control Not yet recruitingThis study aims to evaluate the effects of an individualized enteral nutrition formula on clinical outcomes in critically ill adult patients in the intensive care unit (ICU). Participants will be randomly assigned to one of two groups: the individualized nutrition group or the st…
Sponsor: Chinese Medical Association • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a smartphone platform give ICU teams a head start on danger?
Disease control Not yet recruitingThis study will aim to examine the Effect of integrated Mobile Health Platform on early detection of clinical outcomes of Critical ill patients.
Sponsor: Sohag University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a vaccine train the body to fight Parkinson's?
Vaccine Recruiting nowAn unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy
Phase 1 • Sponsor: Tridem Bioscience FlexCo • Aim: Vaccine
Last updated Aug 22, 2026 00:00 UTC
-
Diabetes drug shows promise to curb alcohol cravings in veterans
Disease control Recruiting nowThis clinical trial aims to test the effectiveness and safety of semaglutide, a GLP-1 receptor agonist, in treating moderate to severe alcohol use disorder (AUD) in Veterans. Participants who qualify will be randomly assigned to receive either semaglutide injections or placebo in…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for brain infection: experimental combo tackles tuberculous meningitis
Disease control Recruiting nowThis two-stage study will compare consented research participants with tuberculous meningitis receiving BPaLMZ to controls receiving SOC of rifampicin (R), isoniazid (H), pyrazinamide (Z), and ethambutol (E), known as RHZE.
Phase 2 • Sponsor: David Boulware • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New heart valve replacement could help thousands avoid Open-Heart surgery
Disease control Recruiting nowPivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.
Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Recruiting nowThe purpose of this study is to assess the ability to slow down or stop the growth of cancer with amivantamab combined with either lazertinib or chemotherapy (carboplatin and pemetrexed) in participants with resectable, epidermal growth factor receptor (EGFR) mutated, Stage II-II…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Custom-Made vaccine aims to stop lung cancer recurrence
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, as well as preliminary efficacy of a personalized cancer vaccine alone and in combination with toripalimab in patients with resected NSCLC. The study included dose escalation an…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a daily pill slow Alzheimer's? new trial tests SAR448851
Disease control Recruiting nowThis is a randomized, placebo-controlled Phase 2 study to evaluate the efficacy and safety of SAR448851 in early Alzheimer's disease (AD) participants. The purpose of this study is to measure efficacy and safety with once daily oral SAR448851 compared to placebo in participants w…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC